Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.

Bibliographic Details
Main Authors:	Shubhadeep D. Sinha, Vamsi Krishna Bandi, Bala Reddy Bheemareddy, Pankaj Thakur, Sreenivasa Chary, Kalpana Mehta, Vikranth Reddy Pinnamareddy, Rajendra Pandey, Subhramanyam Sreepada, Santosh Durugkar
Format:	Article
Language:	English
Published:	BMC 2019-11-01
Series:	BMC Nephrology
Online Access:	http://link.springer.com/article/10.1186/s12882-019-1515-7

id	doaj-c89a8c713e804c20a5bf1e6d8a455d79
record_format	Article
spelling	doaj-c89a8c713e804c20a5bf1e6d8a455d792020-11-25T04:10:36ZengBMCBMC Nephrology1471-23692019-11-012011510.1186/s12882-019-1515-7Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trialShubhadeep D. Sinha0Vamsi Krishna Bandi1Bala Reddy Bheemareddy2Pankaj Thakur3Sreenivasa Chary4Kalpana Mehta5Vikranth Reddy Pinnamareddy6Rajendra Pandey7Subhramanyam Sreepada8Santosh Durugkar9Clinical Development and Medical Affairs, Hetero Group, Hetero CorporateClinical Development and Medical Affairs, Hetero Group, Hetero CorporateClinical Development and Medical Affairs, Hetero Group, Hetero CorporateClinical Development and Medical Affairs, Hetero Group, Hetero CorporateClinical Development and Medical Affairs, Hetero Group, Hetero CorporateDepartment of Nephrology, B.L.Y Nair HospitalCare HospitalsDepartment of Nephrology, Institute of Post Graduate Medical Education and Research KolkataSri Raghavendra HospitalAshwini Hospital and Ramakanth Heart Care CenterFollowing publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.http://link.springer.com/article/10.1186/s12882-019-1515-7
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Shubhadeep D. Sinha Vamsi Krishna Bandi Bala Reddy Bheemareddy Pankaj Thakur Sreenivasa Chary Kalpana Mehta Vikranth Reddy Pinnamareddy Rajendra Pandey Subhramanyam Sreepada Santosh Durugkar
spellingShingle	Shubhadeep D. Sinha Vamsi Krishna Bandi Bala Reddy Bheemareddy Pankaj Thakur Sreenivasa Chary Kalpana Mehta Vikranth Reddy Pinnamareddy Rajendra Pandey Subhramanyam Sreepada Santosh Durugkar Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial BMC Nephrology
author_facet	Shubhadeep D. Sinha Vamsi Krishna Bandi Bala Reddy Bheemareddy Pankaj Thakur Sreenivasa Chary Kalpana Mehta Vikranth Reddy Pinnamareddy Rajendra Pandey Subhramanyam Sreepada Santosh Durugkar
author_sort	Shubhadeep D. Sinha
title	Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
title_short	Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
title_full	Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
title_fullStr	Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
title_full_unstemmed	Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
title_sort	correction to: efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (ckd) undergoing dialysis: a randomized, phase-iii trial
publisher	BMC
series	BMC Nephrology
issn	1471-2369
publishDate	2019-11-01
description	Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.
url	http://link.springer.com/article/10.1186/s12882-019-1515-7
work_keys_str_mv	AT shubhadeepdsinha correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT vamsikrishnabandi correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT balareddybheemareddy correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT pankajthakur correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT sreenivasachary correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT kalpanamehta correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT vikranthreddypinnamareddy correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT rajendrapandey correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT subhramanyamsreepada correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial AT santoshdurugkar correctiontoefficacytolerabilityandsafetyofdarbepoetinalfainjectionforthetreatmentofanemiaassociatedwithchronickidneydiseaseckdundergoingdialysisarandomizedphaseiiitrial
_version_	1724419997479993344

Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

Similar Items